US HB733 | 2011-2012 | 112th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 181-113-1)
Status: Engrossed on September 20 2012 - 50% progression, died in chamber
Action: 2012-09-20 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on September 20 2012 - 50% progression, died in chamber
Action: 2012-09-20 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]
Summary
Recalcitrant Cancer Research Act of 2012 - Amends the Public Health Service Act to require the Director of the National Cancer Institute (NCI) to develop a scientific framework for research on recalcitrant cancers (cancer with a 5-year relative survival rate below 50%), which includes: (1) a review of the status of research, such as a summary of findings, identification of promising scientific advances, a description of the availability of qualified scientific researchers, and the identification of resources available to facilitate research; (2) identification of research questions that have not been adequately addressed; and (3) recommendations for actions to advance research and for appropriate benchmarks to measure progress on achieving such actions. Requires the Director to develop the framework within 18 months and review and update it every 5 years. Requires the Director to identify within 6 months 2 or more recalcitrant cancers that have a 5-year relative survival rate of less than 20%, and are estimated to cause the death of at least 30,000 individuals in the United States per year. Authorizes the Director to identify additional such cancers and to consider additional metrics of progress (such as incidence and mortality rates) against such cancer. Requires the Director to convene a working group for each identified cancer to provide expertise on, and assist in developing, a scientific framework under this Act. Requires the Director to consider each relevant scientific framework developed under this Act when making recommendations for exception funding for grant applications.
Title
Recalcitrant Cancer Research Act of 2012
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2012-09-20 | Senate | Received in the Senate. |
| 2012-09-19 | House | The title of the measure was amended. Agreed to without objection. |
| 2012-09-19 | House | Motion to reconsider laid on the table Agreed to without objection. |
| 2012-09-19 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6144-6145) |
| 2012-09-19 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 733. |
| 2012-09-19 | House | Considered under suspension of the rules. (consideration: CR H6144-6147) |
| 2012-09-19 | House | Mr. Pitts moved to suspend the rules and pass the bill, as amended. |
| 2012-09-11 | House | Forwarded by Subcommittee to Full Committee (Amended) . |
| 2012-09-11 | House | Subcommittee Consideration and Mark-up Session Held. |
| 2011-02-28 | House | Referred to the Subcommittee on Health. |
| 2011-02-16 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
SB362 (Related) 2011-02-16 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
SB3566 (Related) 2012-09-19 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.
SB3560 (Related) 2012-09-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB4310 (Related) 2013-01-02 - Became Public Law No: 112-239.
SB3254 (Related) 2012-12-12 - Pursuant to the provisions of H. Res. 829, papers are returned to the Senate.
SB3566 (Related) 2012-09-19 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.
SB3560 (Related) 2012-09-19 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
HB4310 (Related) 2013-01-02 - Became Public Law No: 112-239.
SB3254 (Related) 2012-12-12 - Pursuant to the provisions of H. Res. 829, papers are returned to the Senate.
Subjects
Advisory bodies
Cancer
Congressional oversight
Department of Health and Human Services
Digestive and metabolic diseases
Drug and radiation therapy
Health
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Medical education
Medical research
Medical tests and diagnostic methods
National Institutes of Health (NIH)
Research administration and funding
Research and development
Cancer
Congressional oversight
Department of Health and Human Services
Digestive and metabolic diseases
Drug and radiation therapy
Health
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Medical education
Medical research
Medical tests and diagnostic methods
National Institutes of Health (NIH)
Research administration and funding
Research and development
